NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
BARDOXOLONE METHYL
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
IJMS | Free Full-Text | Insights into the Molecular Mechanisms of NRF2 in Kidney Injury and Diseases
Can Activation of NRF2 Be a Strategy against COVID-19?: Trends in Pharmacological Sciences
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma - ScienceDirect
Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease | Signal Transduction and Targeted Therapy
Increased albuminuria in bardoxolone methyl–treated type 2 diabetes patients: mere reflection of eGFR improvement? - ScienceDirect
NF‐κB signaling in inflammation and cancer - Zhang - 2021 - MedComm - Wiley Online Library
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
Bardoxolone methyl | 218600-53-4
Frontiers | Bardoxolone Methyl Ameliorates Compression-Induced Oxidative Stress Damage of Nucleus Pulposus Cells and Intervertebral Disc Degeneration Ex Vivo
Bardoxolone methyl breaks the vicious cycle between M1 macrophages and senescent nucleus pulposus cells through the Nrf2/STING/NF-κB pathway - ScienceDirect
Full article: Bardoxolone-methyl inhibits migration and metabolism in MCF7 cells
NF-kB Signaling Pathway products from Selleck Chemicals
Bardoxolone methyl (RTA 402) | Nrf2 Activator | MedChemExpress
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
NF-κB Signaling | NF-kappaB Pathway
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
Bardoxolone (CDDO) | Keap1-Nrf2 Activator | MedChemExpress
